In ₹ Crore except Per Share Latest Annual	SUDARSCHEM FY26	SUDEEPPHRM FY26	STYRENIX FY26	SHARDACROP FY26	Peer Average
Valuation — at last close
P/E	386.07×	72.91×	17.42×	◆ 9.04×	33.12× +1066%
P/B	2.46×	14.45×	2.33×	◆ 1.96×	6.25× -61%
EV/EBITDA	16.29×	57.74×	9.72×	◆ 5.18×	24.21× -33%
Market Cap	₹8,486 Cr	₹12,764 Cr	₹3,187 Cr	₹6,156 Cr	₹7,369 Cr +15%
Growth
Revenue CAGR 3Y	◆ 62.01%	—	13.17%	9.20%	11.18% +454%
Revenue CAGR 5Y	◆ 39.33%	—	16.08%	17.07%	16.57% +137%
Net Income CAGR 3Y	-3.05%	—	-0.03%	◆ 25.81%	12.89% -124%
Revenue YoY (latest Q)	5.39%	20.92%	◆ 24.36%	13.19%	19.49% -72%
Net Income YoY (latest Q)	◆ 88.00%	10.76%	-48.19%	23.36%	-4.69% +1976%
Profitability
EBITDA Margin	6.03%	◆ 34.55%	9.98%	20.43%	21.65% -72%
Net Income Margin	0.42%	◆ 27.14%	5.32%	12.93%	15.13% -97%
Return on Common Equity	0.65%	19.57%	14.43%	◆ 24.16%	19.39% -97%
Return on Capital Employed	3.56%	21.29%	12.97%	◆ 24.51%	19.59% -82%
Return on Assets	0.42%	◆ 14.83%	7.66%	12.96%	11.82% -96%
Credit & Quality
Total Debt/Equity	0.55×	0.17×	0.23×	◆ 0.00×	0.13× +313%
Interest Coverage	1.47×	27.23×	11.78×	◆ 427.86×	155.62× -99%
Scale — latest FY
Revenue / Total Income	₹9,787 Cr	₹642 Cr	₹3,438 Cr	₹5,268 Cr	₹3,116 Cr +214%
Net Income	₹40.8 Cr	₹174 Cr	₹183 Cr	₹681 Cr	₹346 Cr -88%
Total Assets	₹9,723 Cr	₹1,175 Cr	₹2,483 Cr	₹5,780 Cr	₹3,146 Cr +209%
EPS	₹2.8	₹15.5	₹103.98	₹75.47	₹64.98 -96%
Book Value per Share	₹439.52	₹78.21	₹776.75	₹347.65	₹400.87 +10%

◆ best value in the comp set per metric · Δ = subject vs average of the other companies.

« ‹ › »Latest: FY26 · ConsolidatedFA Financial Analysis · alphave

Data & compliance. Descriptive financial information from official NSE/BSE filings — for information and education only, not investment advice, a recommendation, or a valuation. Standalone = parent entity; consolidated includes subsidiaries. Historical multiples pair each fiscal year's filed figures with that FY-end market close; the Current column uses the last close with the latest filed annuals. Figures are cross-verified via accounting identities and NSE×BSE agreement — XBRL cross-verified ✓ 95%.